| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/12/2007 | EP1024834B1 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 09/12/2007 | EP0970127B1 Induction of immunological tolerance to a therapeutic antibody using variants of the said therapeutic antibody |
| 09/12/2007 | CN101035891A Lecithinized superoxide dismutase composition and process for producing the same |
| 09/12/2007 | CN101035563A Multimeric VLA-4 antagonists comprising polymer moieties |
| 09/12/2007 | CN101035551A Nerve growth factor production inhibitor and external preparation for skin, cosmetic, quasi medicine, itch prophylactic and therapeutic agent and atopic dermatitis therapeutic agent mixed with the ner |
| 09/12/2007 | CN101035546A Glycosylceramide adjuvant for saccharide antigens |
| 09/12/2007 | CN101033242A Antenna system for a level measurement apparatus |
| 09/12/2007 | CN101032620A Cyclosporine emulsion and the preparing method |
| 09/12/2007 | CN101032601A Chinese traditional composition to be taken orally for curing lupus sebaceus |
| 09/12/2007 | CN101032541A Echinacea purpurea extractive and the preparing method and the content measuring method |
| 09/12/2007 | CN101032532A Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof |
| 09/12/2007 | CN101032515A Healthy product for improving immunity |
| 09/12/2007 | CN101032300A Fodder for improving immunity of rabbits |
| 09/12/2007 | CN101032282A Sanitarian fodder for dogs |
| 09/12/2007 | CN100336897C Nutrient Songnian wine and its making process |
| 09/12/2007 | CN100336558C Method for preparing cow foremilk immune globulin microcapsulation |
| 09/12/2007 | CN100336542C Glabrous greenbrier total saponin extract and its prepn and use |
| 09/12/2007 | CN100336537C Chinese medicinal composition for antifatigue and increasing immune power and its preparation method |
| 09/11/2007 | US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268141 Xanthine phosphodiesterase V inhibitors |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7268122 Viricides; aids therapy |
| 09/11/2007 | US7268112 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 09/11/2007 | US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 09/11/2007 | US7268108 Alpha-melanocyte stimulating hormone derivatives and cosmetic application thereof |
| 09/11/2007 | US7267963 Modified plant viruses and methods of use thereof |
| 09/11/2007 | US7267822 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/11/2007 | CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 09/11/2007 | CA2254066C Compounds with anti-inflammatory and immunosuppressive activities |
| 09/07/2007 | WO2007101165A1 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/07/2007 | WO2007100643A2 Methods of using antibodies against human il-22 |
| 09/07/2007 | WO2007100566A2 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 09/07/2007 | WO2007100154A1 Immuno-cell therapy for allergic disease using regulatory dendritic cell |
| 09/07/2007 | WO2007100151A1 Immunostimulating agent |
| 09/07/2007 | WO2007100098A1 Multimer of extracellular domain of cell surface functional molecule |
| 09/07/2007 | WO2007100079A1 Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative |
| 09/07/2007 | WO2007099999A1 Novel glycolipid and use thereof |
| 09/07/2007 | WO2007099997A1 Immunostimulating agent and method for production thereof |
| 09/07/2007 | WO2007099921A1 PEPTIDE BINGING TO PILRα, POLYNUCLEOTIDE ENCODING THE SAME AND APPLICATION THEREOF |
| 09/07/2007 | WO2007099537A1 Pro-nanodispersion for the delivery of cyclosporin |
| 09/07/2007 | WO2007099117A1 Thiopyrophosphate organic compounds, method for preparing thereof and compositions containing them |
| 09/07/2007 | WO2007098934A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/07/2007 | WO2007098604A1 Preventing il-2 mediated inflammation in epithelial cells |
| 09/07/2007 | WO2007098575A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | WO2007098557A1 Regulation of immune responses by modulation of the function of antigen presenting cells |
| 09/07/2007 | WO2007084857A3 Methods and compositions for treating cell proliferative disorders |
| 09/07/2007 | WO2007078443A3 Methods of treating unwanted immune response with random copolymers |
| 09/07/2007 | WO2007074135A3 Infant immunological formula |
| 09/07/2007 | WO2007066200A3 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 09/07/2007 | WO2007059761A3 Medicament for treating problems relating to fertility and pregnancy, and auto-immune diseases, and for inducing an immunological tolerance in transplant patients, and method for producing said medicament |
| 09/07/2007 | WO2007056153A3 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| 09/07/2007 | WO2007011760A3 Inhibitors of mitotic kinesin |
| 09/07/2007 | CA2645123A1 Use of dha and ara in the preparation of a composition for regulating gene expression |
| 09/07/2007 | CA2644810A1 Prophylactic or therapeutic agents for allergic ophthalmic diseases or allergic nasal diseases, comprising tricyclic triazolobenzazepine derivative |
| 09/07/2007 | CA2644595A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/07/2007 | CA2644513A1 Preventing il-2 mediated inflammation in epithelial cells |
| 09/07/2007 | CA2644471A1 Pro-nanodispersion for the delivery of cyclosporin |
| 09/07/2007 | CA2644058A1 Regulation of immune responses by modulation of the function of antigen presenting cells |
| 09/07/2007 | CA2643838A1 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/07/2007 | CA2643708A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | CA2642570A1 Methods of using antibodies against human il-22 |
| 09/07/2007 | CA2641513A1 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/07/2007 | CA2641160A1 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
| 09/07/2007 | CA2638832A1 Chimeric vaccine antigens against the avian influenza virus |
| 09/07/2007 | CA2638757A1 Chimeric adenoviral vectors |
| 09/07/2007 | CA2638734A1 Inhibitors of the unfolded protein response and methods for their use |
| 09/06/2007 | US20070208167 Compounds and methods for modulating activation of NF-kappaB |
| 09/06/2007 | US20070208060 Compounds for treating inflammatory diseases |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208025 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 09/06/2007 | US20070207163 Recombinant soluble Fc receptors |
| 09/06/2007 | US20070207159 Compositions and methods for enhancing antigen-specific immune response |
| 09/06/2007 | US20070207146 Therapeutic using a bispecific antibody |
| 09/06/2007 | DE202007001889U1 Oral zu verabreichende Zusammensetzung zur Prävention und/oder Behandlung der Sonnenallergie und/oder des Sonnenbrandes Orally administrable composition for the prevention and / or treatment of sun allergies and / or sunburn |
| 09/05/2007 | EP1830191A2 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications |
| 09/05/2007 | EP1829962A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 09/05/2007 | EP1829961A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 09/05/2007 | EP1829895A1 Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
| 09/05/2007 | EP1829888A1 Anti-inflammatory compounds and uses thereof |
| 09/05/2007 | EP1829887A1 Cpg single-strand deoxynucleotides for use as adjuvant |
| 09/05/2007 | EP1829882A2 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same |
| 09/05/2007 | EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same |
| 09/05/2007 | EP1829535A2 Tissue factor antagonists and methods of use thereof |
| 09/05/2007 | EP1829530A2 Stabilisation of active agents by formulation into nanoparticulate form |
| 09/05/2007 | EP1828248A2 Compositions comprising anti-igf-1 receptor antibodies and methods for obtaining said antibodies |
| 09/05/2007 | EP1828193A1 Pyridil-substituted spiro-hydantoin compounds and use thereof |
| 09/05/2007 | EP1828186A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 09/05/2007 | EP1828160A1 Sulfonyl amino cyclic derivatives and use thereof as mmp inhibitors |
| 09/05/2007 | EP1828114A2 17,20(e)-dehydro vitamin d analogs and their uses |
| 09/05/2007 | EP1828113A2 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses |
| 09/05/2007 | EP1827488A1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 09/05/2007 | EP1827138A1 DRY CONCENTRATE FOR MAKING DIETETIC SOFT DRINK CONTAINING Fe, BEE BREAD AND VITAMIN C AND ITS PRODUCTION PROCESS |